How the DGT's position has evolved
Current position
The reduced rate of 10% applies to products designed to alleviate or treat deficiencies for the personal and exclusive use of persons with physical, mental, intellectual, or sensory deficiencies. To this end, they must be considered prostheses, orthoses, or surgical implants according to current regulations. In vitro diagnostic medical devices for SARS-CoV-2 that do not meet the requirements for the reduced rate are taxed at 21%. Non-reusable plastic packaging containing medical products is exempt from the packaging tax.
The DGT's position remains constant regarding the application of the 10% reduced rate based on the purpose of alleviating deficiencies for personal use. A diversification of the subject matter is observed towards the exemption of plastic packaging and the temporary regulation of a 0% rate for COVID-19 products. There are no changes in the interpretation of the design requirements for the reduced rate.
Turning points
-
Clarifies that masks for immunocompromised individuals are taxed at 21% as they do not meet the requirement of being designed for the personal and exclusive use of persons with deficiencies.
-
Introduces the exemption in the packaging tax for those containing medical products in accordance with Regulation (EU) 2017/745.
Analysis based on 36 of 37 rulings with a stated position. Updated 23 September 2026.